Search Results

Umoja Biopharma, Inc. announced the opening of its new development and manufacturing facility, The Colorado Laboratory & Innovative Manufacturing Building in Louisville, Colo.

AnaBios, a preclinical contract research organization that provides ex vivo human platforms to de-risk new drugs, announced a technology transfer and license agreement with the University of Louisville, Kentucky.

Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.

Research that studies the sensation in the oral cavity is the subject of a grant awarded to Joseph Breza, associate professor of neuroscience at Eastern Michigan University and Robin Krimm, professor of anatomy and neurobiology at University of Louisville.

Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.

IN8bio, Inc. today announced it has selected the UofL Health - Brown Cancer Center GMP Manufacturing Facility at the University of Louisville, home of the Dunbar CAR T-Cell Program, as its manufacturing partner for INB-400.

Meru Health published a randomized controlled trial in collaboration with Stanford University, Harvard University , and University of Louisville today in the Journal of Affective Disorders confirming the utility of therapist-supported holistic digital mental health interventions in reducing depression and anxiety symptoms, insomnia, and associated health burdens.

The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.

Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug designation, while also commercializing diagnostics, today announces the mutual extension of a research agreement with University of Louisville Research Foundation (ULRF).

ONWARD Medical N.V. announces the company and its partners have been awarded nine new patents, seven of them in collaboration with leading neuroscience research laboratories at Caltech, UCLA, EPFL, and University of Louisville.